Laura H. Mariani, MD, MS, is a nephrologist and clinical researcher at the University of Michigan Division of Nephrology. She completed her medical school training at the University of Michigan and subsequently completed her internal medicine residency, chief residency, nephrology fellowship, and Masters of Science in Clinical Epidemiology at the University of Pennsylvania.
Dr. Mariani is currently an Associate Professor in the Division of Nephrology at the University of Michigan. She has a primary clinical and research interest in observational studies in glomerular disease. She is involved in several clinical and translational NIH-funded research studies in kidney diseases, including the Nephrotic Syndrome Study Network (NEPTUNE), the Cure Glomerulonephropathy (CureGN) Consortium, and the Kidney Precision Medicine Program (KPMP) Central Hub.
Her primary research interest is in developing and applying statistical methods for clinical outcome definition and prediction of kidney disease progression as well as linking clinical phenotype to novel biomarkers and high dimensional omics data to better understand disease mechanisms that can be targeted for therapy in glomerular disease.
Day 1 - Sunday April 14, 2024
Time |
Session |
|
9 a.m.
10:30 a.m.
|
HeatherReich
Chairperson
University of Toronto, University Health NetworkCanada
-
Deciphering the IGAN Cell Atlas
-
Complement-mediated Kidney Diseases in the Era of Complement Inhibitors
MarinaVivarelli
Speaker
marina.vivarelli@opbg.netLaboratory of Nephrology, Bambino Gesù Children's HospitalItaly
-
CART-T
JonathanHogan
Speaker
jonathan.hogan@cabalettabio.comCabaletta Bio
-
New Targets to Reduce the Burden of Rare Kidney Diseases
-
Q and A
Hall C4
|
Day 2 - Monday April 15, 2024
Time |
Session |
|
4:30 p.m.
5:30 p.m.
|
DebbieGipson
Chairperson
debbie.gipson@nih.govNational Institutes of Health/NIDDKUnited States
JonathanBarratt
Chairperson
University of Leicester, Leicester, UKUnited Kingdom
-
Patients Subphenotyping: The Example of Diabetic Kidney Disease
John CijiangHe
Speaker
cijiang.he@mssm.eduIcahn School of Medicine at Mount SinaiUnited States
-
Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease
-
Targeted Approaches in Clinical Trial Design
-
Q and A
Hall D
|